| 开盘价:-- | 最高价:-- | 最低价:-- | 52周最高价:-- | 52周最低价:-- |
| 成交量:-- | 平均成交量:-- | 市值:-- | 市盈率:-- | 预期市盈率:-- |
| 每股收益:-- | 贝塔系数:-- | 股息:-- | 收益率:-- | 总股本:-- |
| 证券代码:tmbr | 公司名称:Timber Pharmaceuticals, Inc. | 公司中文简称: |
| 公司简介： Timber Pharmaceuticals, Inc. engages in the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus is on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, facial angiofibroma in tuberous sclerosis complex, and other sclerotic skin diseases. The company was founded in 2019 and is headquartered in Warren, NJ. |
||
| 公司网站： http://www.timberpharma.com |
||
| 公司地址： 3 Mountain View Road Suite 100 Warren |
||